First Time Loading...

Delta-Fly Pharma Inc
TSE:4598

Watchlist Manager
Delta-Fly Pharma Inc Logo
Delta-Fly Pharma Inc
TSE:4598
Watchlist
Price: 739 JPY 1.23%
Updated: May 2, 2024

Delta-Fly Pharma Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Delta-Fly Pharma Inc
Revenue Peer Comparison

Comparables:
2160
4587
4974
J
7774
S
4599

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Delta-Fly Pharma Inc
TSE:4598
Revenue
¥300m
CAGR 3-Years
N/A
CAGR 5-Years
-20%
CAGR 10-Years
N/A
GNI Group Ltd
TSE:2160
Revenue
¥26B
CAGR 3-Years
39%
CAGR 5-Years
39%
CAGR 10-Years
64%
PeptiDream Inc
TSE:4587
Revenue
¥28.7B
CAGR 3-Years
35%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Takara Bio Inc
TSE:4974
Revenue
¥47.7B
CAGR 3-Years
6%
CAGR 5-Years
6%
CAGR 10-Years
8%
J
Japan Tissue Engineering Co Ltd
TSE:7774
Revenue
¥2.4B
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
11%
S
StemRIM Inc
TSE:4599
Revenue
¥2.4B
CAGR 3-Years
4%
CAGR 5-Years
64%
CAGR 10-Years
N/A

See Also

What is Delta-Fly Pharma Inc's Revenue?
Revenue
300m JPY

Based on the financial report for Mar 31, 2022, Delta-Fly Pharma Inc's Revenue amounts to 300m JPY.

What is Delta-Fly Pharma Inc's Revenue growth rate?
Revenue CAGR 5Y
-20%

Over the last year, the Revenue growth was 0%.